enVVeno Medical (NVNO) said Monday that it has appointed Jennifer Bright as its chief financial officer, effective the same day.
The company said Bright brings over 25 years of financial and strategic experience with medical device and pharmaceutical companies such as Biolase, Spectrum Pharmaceuticals, and Teleflex Medical (TFX).
Bright succeeds Craig Glynn, who will continue to serve as an advisor to enVVeno, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.